LASAACI 2020 Fall Symposia

September 26, 2020

This is a live virtual two-hour event with speakers covering the topics of treatment and prevention of asthma as well as approaches to working up primary immunodeficiency.  The LASAACI faculty are experts in their field and will provide evidence-based, clinical topics that address major aspects of the physician's practice and will provide learners exposure to new content.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CBRN
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 2 contact hours.

Commercial Support
This activity is supported by educational grants from Astra Zeneca, CSL Behring, Grifols and Takeda.

Target Audience

Practicing allergists
Allied health professionals

Learning Objectives

Upon completion of this activity the participant should be able to:

  • ​​​​​Follow a world-expert in primary immunodeficiencies on how she approaches the diagnosis and treatment of PIDD
  • Recognize the different monoclonal antibody therapies for severe asthma and future agents in the drug pipeline
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months.  All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations.  It is required that disclosure be provided to the learners prior to the start of the activity.  Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist.  Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.  Disclosure in no way implies that the information presented is biased or of lesser quality.  It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.  Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Attendance
  • 2.00 CBRN
Course opens: 
09/26/2020
Course expires: 
09/26/2022
Event starts: 
09/26/2020 - 8:00am
Event ends: 
09/26/2020 - 11:10am
Rating: 
0

All identified conflicts of interest have been resolved.

Wanda Phipatanakul, MD, MS​ – Speaker
Consultant/consulting fees – Genentech, Novartis
Speaker/honorarium – Novartis, Regeneron
Clinical Trial Support/consulting fees – Circassia, Merck, ALK, Inc., GlaxoSmithKline
Advisory Board Member/consulting fees – Regeneron

Charlotte Cunningham-Rundles, MD, PhD - Speaker
Consultant/consulting fees – CSL Behring, Atara Biotherapeutics,
Advisory Board/consulting fees – Takeda/Shire, UCB Biosciences, Momenta, Pharming

Raffi Tachdjian, MD, MPH – Planner, Chair, Moderator
Speaker/honorarium – Sanofi Regeneron, GlaxoSmithKline, Takeda, CSL Behring, Pharming
Advisory Board Member/consulting fee – Sanofi Regeneron, Takeda, CSL Behring, Pharming

Rita Kachru, MD – Planner
Speaker/honorarium– Aimmune, Genentech

Marc Meth, MD – Planner
Advisory Board Member/consulting fee – Dermira, Sanofi Genzyme, Optinose
Consultant – Regeneron

Sonal Patel, MD – Planner
Speaker/honorarium – Sanofi/Regeneron

The following have no relevant financial relationships to disclose:
Karol Anderson – Planner
Sheila Bonilla, MD – Planner
Dean Chiang, MD – Planner

 

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Attendance
  • 2.00 CBRN
Please login or create an account to take this course.